Abstract:In TSM patients, study have shown that IL-1β and IL-18 levels increased and were consistently associated with the severity of sepsis and outcomes post treatment. Several studies have identified that in fungal-infected macrophages, NLRP3 plays an important in caspase-1 activation and secretion of IL-1β and IL-18. Therefore, in the present study, we aimed to address the role played by the NLRP3 inflammasome in the T. marneffei systemic infection in mice and in vitro.We established T. marneffei infected murine pulmonary model with the Nlrp3-/- mice and Wild type mice.We found that infected mice displayed NLRP3 inflammasome activation and increased production of IL-1β. Further, we demonstrated that T. marneffei conidia activated the NLRP3 inflammasome both in mice and human macrophages. And T. marneffei conidia induced IL-1β release by infected macrophages is NLRP3 inflammasome-dependent. We also found that NLRP3 contributes to development lethality in early stage of pulmonary T. marneffei infection. Moreover, a greater number of MPO-positive cells in the lungs of T. marneffei-infected WT mice and T. marneffei-infected Nlrp3-/- mice showed reduced LDH level, especially in last stage of infection.So, we demonstrated that NLRP3 Inflammasome activation contributes to fungal clearance, neutrophils recruitment and lung injury during T. marneffei Infection.

Nlrp3 Inflammasome Activation Contributes to Fungal Clearance and Lung Injury During Talaromyces Marneffei Infection1